FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
Report of Foreign Issuer
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
For period ending March 28, 2008
GlaxoSmithKline plc
(Name of registrant)
980 Great West Road, Brentford, Middlesex, TW8 9GS
(Address of principal executive offices)
Indicate by check mark whether the registrant files or
will file annual reports under cover Form 20-F
or Form 40-F
Form 20-F x Form 40-F
--
Indicate by check mark whether the registrant by furnishing the
information contained in this Form is also thereby furnishing the
information to the Commission pursuant to Rule 12g3-2(b) under the
Securities Exchange Act of 1934.
Yes No x
--
Issued - Friday 28th March 2008
GlaxoSmithKline plc
Announces Changes to Board Committee
The Board has appointed Mr H Lawrence Culp and Sir Robert Wilson members of
the Nominations Committee with immediate effect.
A table showing the membership of the Board and its committees is attached.
S M Bicknell
Company Secretary
28th March 2008
________________________
Board and Committee Membership
with effect from
28th March 2008
Sir Christopher Gent Chairman
Sir Ian Prosser Senior Independent Non-Executive Director
Dr J-P Garnier Chief Executive Officer
Mr Andrew Witty Executive Director, Chief Executive Officer Designate
Mr Julian S Heslop Chief Financial Officer
Dr Moncef Slaoui Executive Director, Chairman, Research & Development
Mr Chris Viehbacher Executive Director, President, US Pharmaceuticals
Professor Sir Roy Anderson Independent Non-Executive Director
Dr Stephanie Burns Independent Non-Executive Director
Mr H Lawrence Culp Independent Non-Executive Director
Sir Crispin Davis Independent Non-Executive Director
Sir Deryck Maughan Independent Non-Executive Director
Dr Dan Podolsky Independent Non-Executive Director
Dr Ronaldo Schmitz Independent Non-Executive Director
Mr Tom De Swaan Independent Non Executive Director
Sir Robert Wilson Independent Non-Executive Director
Board Committee Committee Chairman Members
Audit Mr Tom De Swaan Sir Deryck Maughan
Dr Dan Podolsky
Sir Ian Prosser
Dr Ronaldo Schmitz
Sir Robert Wilson
Remuneration Sir Robert Wilson Mr H Lawrence Culp
Sir Crispin Davis
Sir Christopher Gent
Dr Ronaldo Schmitz
Nominations Sir Christopher Gent Mr H Lawrence Culp
Sir Ian Prosser
Dr Ronaldo Schmitz
Sir Robert Wilson
Corporate Responsibility Sir Christopher Gent Dr Stephanie Burns
Sir Ian Prosser
Dr Dan Podolsky
Mr Tom de Swaan
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorised.
GlaxoSmithKline plc
(Registrant)
Date: March 28, 2008 By: VICTORIA WHYTE
------------------
Victoria Whyte
Authorised Signatory for and on
behalf of GlaxoSmithKline plc